Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-875 Phase 3 outpatient study in Japan
jRCT2080221565Phase 3
- Sponsor
- Takeda
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of fasiglifam in type 2 diabetes mellitus (T2DM), sponsored by Takeda.
02
Drugs
fasiglifam
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080221565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221565.